Rigel Pharmaceuticals, Inc.
Rigel Pharmaceuticals, Inc. (RIGL) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · RIGL · as of Sep 30, 2025
Ownership Breakdown
170
Institutional Holders
▲ 46 vs Q2
$424.67M
Total Inst. Value
▲ $164.37M vs Q2
18.50M
Shares Outstanding
freeFloat 96.66%
14.99M
13F Shares Held
▲ 1.10M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
RIGL largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BLACKROCK, INC. pharmaceutical preparations | 1.72M | 9.64% | 9.64% | $48.87B | Nov 12, 2025 | ▲ 99.1K |
VANGUARD GROUP INC pharmaceutical preparations | 1.04M | 5.83% | 5.83% | $29.55B | Nov 7, 2025 | ▼ 9.7K |
GOLDMAN SACHS GROUP INC pharmaceutical preparations | 737.0K | 4.12% | 4.12% | $20.88B | Nov 14, 2025 | ▲ 554.8K |
ARMISTICE CAPITAL, LLC pharmaceutical preparations | 724.0K | 4.05% | 4.05% | $20.51B | Nov 17, 2025 | ▼ 876.0K |
ACADIAN ASSET MANAGEMENT LLC pharmaceutical preparations | 685.7K | 3.83% | 3.83% | $19.41B | Nov 13, 2025 | ▲ 62.7K |
MARSHALL WACE, LLP pharmaceutical preparations | 601.3K | 3.36% | 3.36% | $17.04B | Nov 13, 2025 | ▲ 232.4K |
CAPITOLIS LIQUID GLOBAL MARKETS LLC pharmaceutical preparations | 591.6K | 3.31% | 3.31% | $16.76B | Nov 14, 2025 | — held |
STATE STREET CORP pharmaceutical preparations | 554.3K | 3.10% | 3.10% | $15.70B | Nov 14, 2025 | ▼ 45.9K |
RENAISSANCE TECHNOLOGIES LLC pharmaceutical preparations | 474.2K | 2.65% | 2.65% | $13.43B | Nov 13, 2025 | ▲ 237.8K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 423.7K | 2.37% | 2.37% | $12.01B | Nov 12, 2025 | ▲ 8.1K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
31
Increased
+3.32M shares6
New Positions
first time holders12
Decreased
−2.83M shares0
Sold Out
fully exitedNet shares change (top 50)
+488.1K
+3.32M / −2.83M
Net new holders
+25
6 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
RIGL insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
7
Buy transactions
1
Sell transactions
7.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Schorno Dean L EVP & Chief Financial Officer | Jun 1, 2026 | Tax Withhold | 928 | $29.86 | $27.7K | 78.8K | Form 4 ↗ |
Santos David A EVP, Chief Commercial Officer | Jun 1, 2026 | Tax Withhold | 874 | $29.86 | $26.1K | 62.0K | Form 4 ↗ |
Rojkjaer Lisa EVP, Chief Medical Officer | Jun 1, 2026 | Tax Withhold | 850 | $29.86 | $25.4K | 34.0K | Form 4 ↗ |
RODRIGUEZ RAUL R CEO, President | Jun 1, 2026 | Tax Withhold | 2,424 | $29.86 | $72.4K | 279.6K | Form 4 ↗ |
Furey Raymond J. EVP, GC, CCO & Corp Sec | Jun 1, 2026 | Tax Withhold | 877 | $29.86 | $26.2K | 50.9K | Form 4 ↗ |
Ali-Jackson Kamil director | May 26, 2026 | Sale | 2,500 | $29.17 | $72.9K | 12.6K | Form 4 ↗ |
Wasman Jane director | May 15, 2026 | Award | 5,750 | — | — | 18.3K | Form 4 ↗ |
MOOS WALTER H director | May 15, 2026 | Award | 5,750 | — | — | 18.5K | Form 4 ↗ |
MILLER MICHAEL PATRICK director | May 15, 2026 | Award | 5,750 | — | — | 5.9K | Form 4 ↗ |
LAPOINTE ANTHONY GREGG director | May 15, 2026 | Award | 5,750 | — | — | 18.3K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Rigel Pharmaceuticals, Inc. (RIGL) is primarily owned by institutional investors, who hold approximately 81.0% of total shares outstanding. Company insiders own approximately 3.34%, while retail and public investors account for the remaining 15.65%.
The largest institutional shareholder of Rigel Pharmaceuticals, Inc. is BLACKROCK, INC., holding approximately 1.72 million shares — equal to 9.64% of outstanding shares — as of September 30, 2025.
A total of 170 institutional investors currently hold RIGL stock, with a combined institutional value of approximately $424,666,568 as of the most recent 13F filing period.
Frequently asked questions
RIGL ownershipRigel Pharmaceuticals, Inc. (RIGL) is primarily owned by institutional investors, who hold approximately 81.0% of shares. The largest shareholder is BLACKROCK, INC. with a 9.64% stake. Company insiders hold 3.34%. Data sourced from SEC Form 13F as of September 30, 2025.